IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypes

Aurore Moussiegt¹, Romain Müller², Mikaël Ebbo³, Aurélie Grados⁴, Julie Graveleau⁵, Felix Ackermann¹, Claude Bachmeyer⁶, Emmanuelle Bernit², Philippe Blanche⁷, Etienne Canoui⁸, Fabrice Chaix⁹, Nathalie Costedoat-Chalumeau⁷, Pascal De Groote¹⁰, Nicolas Etienne¹¹, Renato Fior¹², Edouard Flamarion¹³, Titouan Kennel¹⁴, David Launay¹⁵, Nathalie Lerolle¹⁶, Nicolas Limal¹⁷, Valentine Loustau¹⁸, Elodie Menage¹⁹, Guillaume Moulis²⁰, Thomas Papo²¹, Jacques Pouchot¹³, Thomas Quemeneur²², Mathilde Roumier¹, Colas Tchérakian²³, Guillaume Lefèvre¹¹, Vinciane Rebours²⁴, Jean-Emmanuel Kahn²⁵, Nicolas Schleinitz³, Matthieu Groh²⁶; CEREO; French IgG4-RD Study Group

Affiliations

¹ Department of Internal Medicine, Hôpital Foch, Suresnes, France; National Referrence Center for Hypereosinophilic Syndromes, CEREO, France.
² Department of Internal Medicine, Hôpital La Timone, CHU Marseille, Aix-Marseille Université, Marseille, France.
³ National Referrence Center for Hypereosinophilic Syndromes, CEREO, France; Department of Internal Medicine, Hôpital La Timone, CHU Marseille, Aix-Marseille Université, Marseille, France.
⁴ Department of Internal medicine, CH de Niort, Niort, France.
⁵ Department of Internal Medicine, CH de St Nazaire, St Nazaire, France.
⁶ Department of Internal Medicine, hôpital Tenon, Paris, France.
⁷ Department of Internal Medicine, National Referrence Center for Systemic and Autoimmune Diseases, hôpital Cochin, Paris, France.
⁸ Department of Internal Medicine, Hôpital Beaujon, Clichy, France.
⁹ Department of Internal Medicine, Centre hospitalier de la Polynésie Française, Tahiti, France.
¹⁰ Department of cardiology, CHU de Lille, Lille, France.
¹¹ National Referrence Center for Hypereosinophilic Syndromes, CEREO, France; Department of Internal Medicine and Clinical Immunology, National Referrence Center for Systemic and Autoimmune Diseases, (CeRAINO), CHU de Lille, Lille, France.
¹² Department of Internal Medicine, CHU Antoine-Béclère, Clarmart, France.
¹³ Department of Internal Medicine, hôpital Européen Georges Pompidou, Paris, France.
¹⁴ Clinical Research Department, Hôpital Foch, Suresnes, France.
¹⁵ Department of Internal Medicine and Clinical Immunology, National Referrence Center for Systemic and Autoimmune Diseases, (CeRAINO), CHU de Lille, Lille, France; Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
¹⁶ Department of Internal Medicine, CHU du Kremlin Bicêtre, Kremlin Bicêtre, France.
¹⁷ Department of Internal Medicine, hôpital Henri Mondor, Créteil, France.
¹⁸ Department of Internal Medicine, CH Alpes Léman, Contamine-sur-Arve, France.
¹⁹ Department of Internal Medicine, groupe hospitalier Paris St Joseph, Paris, France.
²⁰ Department of Internal Medicine, hôpital Purpan, CHU Toulouse, Toulouse, France.
²¹ Department of Internal Medicine, hôpital Bichat, Paris, France.
²² Department of Internal Medicine, CH de Valenciennes, Valenciennes, France.
²³ National Referrence Center for Hypereosinophilic Syndromes, CEREO, France; Department of Respiratory Medicine, hôpital Foch, Suresnes, France.
²⁴ Department of Pancreatology, hôpital Beaujon, Clichy, France.
²⁵ National Referrence Center for Hypereosinophilic Syndromes, CEREO, France; Department of Internal Medicine, hôpital Ambroise-Paré, Boulogne-Billancourt, France.
²⁶ Department of Internal Medicine, Hôpital Foch, Suresnes, France; National Referrence Center for Hypereosinophilic Syndromes, CEREO, France. Electronic address: France.m.groh@hopital-foch.com.

PMID: 34237420
DOI: 10.1016/j.autrev.2021.102889

IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypes

Aurore Moussiegt et al. Autoimmun Rev. 2021 Sep.

. 2021 Sep;20(9):102889.

doi: 10.1016/j.autrev.2021.102889. Epub 2021 Jul 5.

Authors

Affiliations

¹ Department of Internal Medicine, Hôpital Foch, Suresnes, France; National Referrence Center for Hypereosinophilic Syndromes, CEREO, France.
² Department of Internal Medicine, Hôpital La Timone, CHU Marseille, Aix-Marseille Université, Marseille, France.
³ National Referrence Center for Hypereosinophilic Syndromes, CEREO, France; Department of Internal Medicine, Hôpital La Timone, CHU Marseille, Aix-Marseille Université, Marseille, France.
⁴ Department of Internal medicine, CH de Niort, Niort, France.
⁵ Department of Internal Medicine, CH de St Nazaire, St Nazaire, France.
⁶ Department of Internal Medicine, hôpital Tenon, Paris, France.
⁷ Department of Internal Medicine, National Referrence Center for Systemic and Autoimmune Diseases, hôpital Cochin, Paris, France.
⁸ Department of Internal Medicine, Hôpital Beaujon, Clichy, France.
⁹ Department of Internal Medicine, Centre hospitalier de la Polynésie Française, Tahiti, France.
¹⁰ Department of cardiology, CHU de Lille, Lille, France.
¹¹ National Referrence Center for Hypereosinophilic Syndromes, CEREO, France; Department of Internal Medicine and Clinical Immunology, National Referrence Center for Systemic and Autoimmune Diseases, (CeRAINO), CHU de Lille, Lille, France.
¹² Department of Internal Medicine, CHU Antoine-Béclère, Clarmart, France.
¹³ Department of Internal Medicine, hôpital Européen Georges Pompidou, Paris, France.
¹⁴ Clinical Research Department, Hôpital Foch, Suresnes, France.
¹⁵ Department of Internal Medicine and Clinical Immunology, National Referrence Center for Systemic and Autoimmune Diseases, (CeRAINO), CHU de Lille, Lille, France; Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.
¹⁶ Department of Internal Medicine, CHU du Kremlin Bicêtre, Kremlin Bicêtre, France.
¹⁷ Department of Internal Medicine, hôpital Henri Mondor, Créteil, France.
¹⁸ Department of Internal Medicine, CH Alpes Léman, Contamine-sur-Arve, France.
¹⁹ Department of Internal Medicine, groupe hospitalier Paris St Joseph, Paris, France.
²⁰ Department of Internal Medicine, hôpital Purpan, CHU Toulouse, Toulouse, France.
²¹ Department of Internal Medicine, hôpital Bichat, Paris, France.
²² Department of Internal Medicine, CH de Valenciennes, Valenciennes, France.
²³ National Referrence Center for Hypereosinophilic Syndromes, CEREO, France; Department of Respiratory Medicine, hôpital Foch, Suresnes, France.
²⁴ Department of Pancreatology, hôpital Beaujon, Clichy, France.
²⁵ National Referrence Center for Hypereosinophilic Syndromes, CEREO, France; Department of Internal Medicine, hôpital Ambroise-Paré, Boulogne-Billancourt, France.
²⁶ Department of Internal Medicine, Hôpital Foch, Suresnes, France; National Referrence Center for Hypereosinophilic Syndromes, CEREO, France. Electronic address: France.m.groh@hopital-foch.com.

PMID: 34237420
DOI: 10.1016/j.autrev.2021.102889

No abstract available

Keywords: Hypereosinophilic syndrome; Hypergammaglobulinemia; IgG4-related disease; Interleukin-5; Rituximab.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypes

Affiliations

IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypes

Authors

Affiliations

Publication types

MeSH terms

Substances